Akonni Biosystems Inc.

Frederick, MD

UEI
PGLAYC4UKDL7
CAGE
3YNV1
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
400 Sagner Ave # 300, Frederick, MD 21701, USA
Website
akonni.com
Founded
2003
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $217,499

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of California, San Diego Sub: 280,000.00 11/28/2023 Mod: 280,000.00 06/04/2024 Mod: 5,540.00 Mod: 154,000.00 09/05/2025 Statement of Work Akonni Biosystems Site PI: Christopher… R01AI176401 $719,540

Similar vendors

About the company

Akonni Biosystems Inc. is a molecular diagnostics company that develops, manufactures, and markets integrated molecular diagnostic systems, including TruTip sample prep kits and the TruDiagnosis system for multiplexed diagnostics. Akonni Biosystems provides goods and services to the federal government through both federal contracts and grants.

Through a $365,000 definitive contract with the Department of the Navy's Secretary of the Navy Office of Naval Research, Akonni Biosystems will deliver Phase I and Phase II TRUTIP Alpha prototype kits. This contract was awarded under a broad agency announcement seeking innovative research proposals. Under this firm fixed price contract to be performed in Frederick, Maryland, there was no set-aside designation.

Akonni Biosystems has also been awarded federal grants from the Department of Health and Human Services to develop multiplexed diagnostic tests. A $504,261 project grant from the Food and Drug Administration supports developing a lateral flow array to detect undeclared food allergens. Two project grants totaling $3.9 million from the National Institutes of Health National Institute of Allergy and Infectious Diseases fund developing a lab-on-a-film platform to identify respiratory mycobacterial infections, differentiate tuberculosis, and detect antimicrobial resistance. Partners on the respiratory infection diagnostic grants include Mayo Clinic, National Jewish Health, and Wadsworth Center.

SBA capabilities narrative

Research, develop and manufacture next generation molecular diagnostic tests, hardware and software systems.

Quick answers

Is Akonni Biosystems Inc. registered in SAM.gov?

Akonni Biosystems Inc.'s SAM.gov registration expired on August 24, 2026.

What is Akonni Biosystems Inc.'s CAGE code?

Akonni Biosystems Inc.'s CAGE code is 3YNV1, and its Unique Entity ID (UEI) is PGLAYC4UKDL7.

How much has Akonni Biosystems Inc. received in federal contracts?

Federal contracts obligated $217,499 to Akonni Biosystems Inc. in fiscal years 2023 through 2027.

What is Akonni Biosystems Inc.'s most recent federal award?

Akonni Biosystems Inc.'s most recent federal contract award is Phase I & phase II - trutip alpha prototype kits (N0017322C2008), from Office of Naval Research (SECNAV), on September 22, 2022.

On GovTribe

See Akonni Biosystems Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe